HONOLULU — The investigational dopamine-1 (D1) receptor antagonist ecopipam (developed by Emalex Biosciences) is safe and effective for the improvement of Tourette syndrome (TS) symptoms in children, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback